CD8A and neoplasm: In addition, a high number of tumor‐infiltrating lymphocytes, especially CD8+ cytotoxic T lymphocytes and B lymphocytes, and PD‐L1 expression on peritumoral immune cells, mainly macrophages, are associated with treatment response [21].